Alzamend Neuro, Inc. (ALZN)
1.02
-0.04
(-3.77%)
USD |
NASDAQ |
Apr 01, 16:00
0.9833
-0.04
(-3.60%)
After-Hours: 20:00
Alzamend Neuro Total Liabilities (Quarterly) : 1.857M for Jan. 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Allogene Therapeutics, Inc. | 123.36M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Agenus, Inc. | 504.66M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| Savara, Inc. | 50.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.042M |
| Shareholders Equity (Quarterly) | 2.184M |
| Current Ratio | 1.992 |